These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 36422314)

  • 1. A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment.
    Scanlan A; Zhang Z; Koneru R; Reece M; Gavegnano C; Anderson AM; Tyor W
    Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?
    Bandera A; Taramasso L; Bozzi G; Muscatello A; Robinson JA; Burdo TH; Gori A
    Front Aging Neurosci; 2019; 11():187. PubMed ID: 31427955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI.
    Murphy AJ; Kelschenbach J; He H; Chao W; Kim BH; Volsky DJ; Berman JW
    Front Immunol; 2022; 13():1004985. PubMed ID: 36275760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy.
    Opsteen S; Moylan D; Taiwo BO; Robertson KR; Overton ET; Cutter GR; Sabbaj S; Heath SL; Shacka JJ
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):485-489. PubMed ID: 36083516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru.
    Diaz MM; Zacarías MG; Sotolongo P; Sanes MF; Franklin DJ; Marquine MJ; Cherner M; Cárcamo C; Ellis RJ; Lanata S; García PJ
    Front Neurol; 2021; 12():629257. PubMed ID: 34220665
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurocognitive impairment and characteristics of neurocognitive performance among people with HIV on antiretroviral treatment].
    Xia JJ; Wang SL; Hu YF; Shen WW; Lin HJ; Shi RZ; Ma ZH; Li ZH; Li SZ; Ding YY; Chen XX; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1651-1657. PubMed ID: 36456499
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives.
    Moschopoulos CD; Alford K; Antoniadou A; Vera JH
    Trends Mol Med; 2024 Jul; ():. PubMed ID: 38955654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.
    Letendre SL; Chen H; McKhann A; Roa J; Vecchio A; Daar ES; Berzins B; Hunt PW; Marra CM; Campbell TB; Coombs RW; Ma Q; Swaminathan S; Macatangay BJC; Morse GD; Miller T; Rusin D; Greninger AL; Ha B; Alston-Smith B; Robertson K; Paul R; Spudich S;
    Clin Infect Dis; 2023 Sep; 77(6):866-874. PubMed ID: 37183889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy.
    Guha D; Misra V; Yin J; Gabuzda D
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
    Santos GMA; Locatelli I; Métral M; Calmy A; Lecompte TD; Nadin I; Hauser C; Cusini A; Hasse B; Kovari H; Tarr P; Stoeckle M; Fux C; Di Benedetto C; Schmid P; Darling KEA; Du Pasquier R; Cavassini M;
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz277. PubMed ID: 31304188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between HIV-1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post-mortem brain tissue.
    Williams ME; Naudé PJW
    Rev Med Virol; 2024 Jan; 34(1):e2519. PubMed ID: 38282400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
    Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
    PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV.
    Mastrorosa I; Pinnetti C; Brita AC; Mondi A; Lorenzini P; Del Duca G; Vergori A; Mazzotta V; Gagliardini R; Camici M; De Zottis F; Fusto M; Plazzi MM; Grilli E; Bellagamba R; Cicalini S; Antinori A
    Clin Infect Dis; 2023 Feb; 76(3):e629-e637. PubMed ID: 35982541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV.
    Volpe K; Samuels D; Kallianpur A; Ellis R; Franklin D; Letendre S; Heaton RK; Hulgan T
    J Neurovirol; 2021 Aug; 27(4):557-567. PubMed ID: 34101088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
    Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
    Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Neurocognitive Impairment (NCI) Is Associated With Incident Frailty but Baseline Frailty Does Not Predict Incident NCI in Older Persons With Human Immunodeficiency Virus (HIV).
    Masters MC; Perez J; Wu K; Ellis RJ; Goodkin K; Koletar SL; Andrade A; Yang J; Brown TT; Palella FJ; Sacktor N; Tassiopoulos K; Erlandson KM
    Clin Infect Dis; 2021 Aug; 73(4):680-688. PubMed ID: 34398957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput screening assay for silencing established HIV-1 macrophage infection identifies nucleoside analogs that perturb H3K9me3 on proviral genomes.
    Yi Y; Zankharia U; Cassel JA; Lu F; Salvino JM; Lieberman PM; Collman RG
    J Virol; 2023 Aug; 97(8):e0065323. PubMed ID: 37578230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
    Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
    J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
    Heaton RK; Franklin DR; Ellis RJ; McCutchan JA; Letendre SL; Leblanc S; Corkran SH; Duarte NA; Clifford DB; Woods SP; Collier AC; Marra CM; Morgello S; Mindt MR; Taylor MJ; Marcotte TD; Atkinson JH; Wolfson T; Gelman BB; McArthur JC; Simpson DM; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I; ;
    J Neurovirol; 2011 Feb; 17(1):3-16. PubMed ID: 21174240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.